Avior Wealth Management’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
Other funds holding BPMC
RSCM
Avior Wealth Management's BPMC Position: Q2 2024 in Review
Avior Wealth Management sold out of Blueprint Medicines (BPMC) in Q2 2024, closing a stake of 131 shares — an estimated $12.4K sold.
Avior Wealth Management first reported a position in BPMC in Q3 2018 and held it in 19 quarters. The position peaked at $808K in Q4 2021. 305 funds tracked by Wall St. Rank hold BPMC as of Q2 2024.
- Avior Wealth Management reported no remaining Blueprint Medicines position as of Q2 2024 after selling out during the quarter.
- Avior Wealth Management sold 131 Blueprint Medicines shares in Q2 2024, an estimated $12.4K.
- Avior Wealth Management first reported a position in Blueprint Medicines in Q3 2018 and held it in 19 quarters.
- Avior Wealth Management's Blueprint Medicines position peaked at $808K in Q4 2021.
- 305 funds tracked by Wall St. Rank held Blueprint Medicines as of Q2 2024.
Based on Avior Wealth Management's 13F filing for Q2 2024, filed 13 Aug 2024.